References
Grasso M, Remacle M, Bachy V, Van Der Vorst S, Lawson G (2014) Use of cidofovir in HPV patients with recurrent respiratory papillomatosis. Eur Arch Otorhinolaryngol 271:2983–2990
Dikkers FG (2006) Treatment of recurrent respiratory papillomatosis with microsurgery in combination with intralesional cidofovir–a prospective study. Eur Arch Otorhinolaryngol 263:440–443
Tjon Pian Gi RE, Ilmarinen T, van den Heuvel ER, Aaltonen LM, Andersen J, Brunings JW, Chirila M, Dietz A, Ferran Vila F, Friedrich G, de Gier HH, Golusinski W, Graupp M, Hantzakos A, Horcasitas R, Jackowska J, Koelmel JC, Lawson G, Lindner F, Remacle M, Sittel C, Weichbold V, Wierzbicka M, Dikkers FG (2013) Safety of intralesional cidofovir in patients with recurrent respiratory papillomatosis: an international retrospective study on 635 RRP patients. Eur Arch Otorhinolaryngol 270:1679–1687
Tjon Pian Gi RE, San Giorgi MR, Slagter-Menkema L, van Hemel BM, van der Laan BF, van den Heuvel ER, Dikkers FG, Schuuring E (2014) Clinical course of recurrent respiratory papillomatosis: comparison between aggressiveness of human papillomavirus-6 and human papillomavirus-11. Head Neck (in press)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
San Giorgi, M.R.M., Tjon Pian Gi, R.E.A. & Dikkers, F.G. The clinical course of recurrent respiratory papillomatosis after the use of cidofovir is influenced by multiple factors. Eur Arch Otorhinolaryngol 272, 1819–1820 (2015). https://doi.org/10.1007/s00405-014-3366-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-014-3366-y